心脏手术后早期使用对乙酰氨基酚与严重急性肾损伤的关系
该回顾性观察性队列研究基于MIMIC-III和eICU两个公共临床数据库,纳入心脏手术后成人患者,分析术后48小时内使用对乙酰氨基酚与术后7天内严重急性肾损伤(KDIGO 2期或3期)的关联。多变量回归显示,两个队列中早期使用对乙酰氨基酚均与严重急性肾损伤风险降低相关(MIMIC-III AHR 0.86,95%CI 0.79-0.94;eICU AHR 0.84,95%CI 0.72-0.97)。作者结论认为该关联为独立相关,并呼吁开展前瞻性试验验证因果性。
要点
- 心脏手术后早期使用对乙酰氨基酚与严重急性肾损伤风险降低独立相关。
- MIMIC-III队列AHR 0.86(95%CI 0.79-0.94),eICU队列AHR 0.84(95%CI 0.72-0.97)。
- 作者指出需前瞻性试验评估因果性及预防严重程度的潜力。
核心结论
- 心脏手术后早期使用对乙酰氨基酚与成人严重急性肾损伤风险降低独立相关。
- 作者认为需前瞻性试验评估该关联的因果性及对乙酰氨基酚可能预防或减轻急性肾损伤严重程度的程度。
研究设计与样本
- 回顾性观察性队列研究,数据来自MIMIC-III和eICU两个公共临床数据库。
- 纳入年龄≥18岁的心脏手术后患者,MIMIC-III队列5791例,eICU队列3840例。
- 暴露为术后48小时内使用对乙酰氨基酚,结局为术后7天内KDIGO 2期或3期急性肾损伤。
- 采用多变量病因特异性风险回归分析。
主要发现
- MIMIC-III队列严重急性肾损伤总体发生率为58%(3390例),eICU队列为37%(1431例)。
- MIMIC-III队列术后早期使用对乙酰氨基酚者4185例(72%),eICU队列2737例(71%)。
- MIMIC-III队列早期使用对乙酰氨基酚与严重急性肾损伤风险降低相关,AHR 0.86(95%CI 0.79-0.94)。
- eICU队列早期使用对乙酰氨基酚与严重急性肾损伤风险降低相关,AHR 0.84(95%CI 0.72-0.97)。
- 敏感性分析和亚组分析结果一致。
局限性
- 原文报告无对乙酰氨基酚剂量数据。
- 作者结论指出需前瞻性试验评估观察到的关联在多大程度上具有因果性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE & OBJECTIVE: Oxidative stress may contribute to the development of acute kidney injury (AKI) after cardiac surgery. Acetaminophen can be considered an antioxidant because it inhibits hemoprotein-catalyzed lipid peroxidation. We hypothesized that perioperative acetaminophen administration is associated with reduced AKI after cardiac surgery. STUDY DESIGN: Retrospective observational cohort study. SETTING & PARTICIPANTS: Patients aged≥18 years who had cardiac surgery were identified from 2 publicly available clinical registries: the Medical Information Mart for Intensive Care III (MIMIC-III) and the eICU Collaborative Research Database (eICU). EXPOSURE: Administration of acetaminophen in the first 48 hours after surgery. OUTCOME: Severe AKI in the first 7 days after surgery, defined as stage 2 or stage 3 AKI according to KDIGO criteria. ANALYTICAL APPROACH: Multivariable cause-specific hazards regression analysis. RESULTS: We identified 5,791 patients from the MIMIC-III and 3,840 patients from the eICU registries. The overall incidence of severe AKI was 58% (3,390 patients) in the MIMIC-III cohort and 37% (1,431 patients) in the eICU cohort. Acetaminophen was administered in the early postoperative period to 4,185 patients (72%) and 2,737 patients (71%) in these 2 cohorts, respectively. In multivariable regression models, early postoperative use of acetaminophen was associated with a lower risk of severe AKI in both the MIMIC-III (adjusted hazard ratio [AHR], 0.86 [95% CI, 0.79-0.94]) and eICU (AHR, 0.84 [95% CI, 0.72-0.97]) cohorts. The benefit was consistent across sensitivity and subgroup analyses. LIMITATIONS: No data on acetaminophen dose. CONCLUSIONS: Early postoperative acetaminophen administration was independently associated with a lower risk of severe AKI in adults recovering from cardiac surgery. Prospective trials are warranted to assess the extent to which the observed association is causal and estimate the extent to which acetaminophen administration might prevent or reduce the severity of AKI. PLAIN-LANGUAGE SUMMARY: There is uncertainty about whether antioxidant medications such as acetaminophen may protect against kidney injury. Therefore, we evaluated the associations between acetaminophen use and kidney outcomes in adults recovering from cardiac surgery in 2 large clinical registries. Acetaminophen treatment was significantly associated with a 14%-16% lower risk of severe and any-stage acute kidney injury but similar risks of kidney replacement therapy and in-hospital mortality. Our findings suggest that acetaminophen use may protect against kidney injury in adult patients recovering from cardiac surgery.
引用
- Xiong C, Jia Y, Wu X, et al. Early Postoperative Acetaminophen Administration and Severe Acute Kidney Injury After Cardiac Surgery. Am J Kidney Dis. 2022. PMID: 36586561. doi:10.1053/j.ajkd.2022.11.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。